Skip to main content

Table 3 Site wise treatment outcome and parasite clearance time with artemether-lumefantrine

From: Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India

S. no. Outcome of treatment (28 days) MP CG MH OD Total
n (%) n (%) n (%) n (%) n (%)
1 Primary classification
 ACPR. 103 (100) 104 (96.3) 82 (100) 63(100) 352 (98.9)
 ETF 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 LCF 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 LPF 0 (0.0) 4 (3.7) 0 (0.0) 0 (0.0) 4 (1.1)
 Loss to follow-up 0 (0.0) 4 (3.4) 0 (0.0) 4 (5.6) 8 (2.1)
 Withdrawal 2 (1.9) 5 (4.3) 0 (0.0) 5 (6.9) 12 (3.2)
 Total 105 (100) 117 (100) 82 (100) 72 (100) 376 (100)
2 Parasite clearance time (hours)
 ≤ 24 86 (83.5) 39 (36.1) 79 (96.3) 24(38.1) 228 (64.0)
 > 24–48 17 (16.5) 68(63.0) 3 (3.7) 37 (58.7) 125 (35.1)
 > 48–72 0 (0.0) 1 (0.9) 0 (0.0) 2 (3.2) 3 (0.8)
 > 72 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  1. ACPR adequate clinical and parasitological response, ETF early treatment failure, LCF late clinical failure, LPF late parasitological failure, MP Madhya Pradesh, CG Chhattisgarh, MH Maharashtra, OD Odisha